Home › Cystic Fibrosis › NCT06837181
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
RecruitingObservational study
Who can join
Ages 12 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Written informed consent (and assent when applicable) obtained from participant or participant's legally authorized representative * For Adults: Must be able to consent on one own's behalf (i.e., cannot lack cognitive capacity to consent due to the required patient-reported outcomes) * Be willing and able to adhere to the study protocol requirements * Age ≥ 12 years at time of enrollment * CF diagnosis based on two CF causing mutations and/or positive sweat test according to CFF diagnostic criteria * CFRD diagnosis ≥ 5 years at time of enrollment Exclusion Criteria: * History of any illness or condition that, in the opinion of the investigator might confound the results of the study or pose an additional risk to the subject * History of transplant * Pregnancy reported by participant at time of consent or at any point during active study participation Pulse Wave Velocity Exclusion Criteria: * Erratic, accelerated or mechanically controlled irregular heart rhythms including arrhythmias * Carotid or aortic valve stenosis * Peripheral artery disease or leg artery disease * Generalized constriction or localized spasm of muscular conduit arteries such as seen immediately after hypothermic cardiopulmonary bypass surgery or accompanying Raynaud's phenomena or intense cold. * Possible exclusions based on investigator medical provider assessment (additional precautions may be followed to allow inclusion): * Pressure reading should not be conducted on a limb where there is intravenous access, arterio-venous shunt, or where circulation is compromised. * Pressure reading should not be conducted on the side of the body that a mastectomy was done.
About the study
This multicenter cross-sectional study will include a diverse population of adolescents and adults with CF.
The overall Aim is to describe prevalence of diabetes microvascular complications and macrovascular surrogates in people with established CFRD.
What is being tested
- observational study (other)
Sponsor: Jaeb Center for Health Research · Participants: 200 · Started: Sep 18, 2025
Contact the study team
- Judy Sibayan, MPH, CCRP · Phone: 813-975-8690
- Haley Fonseca, PhD, RDN, LDN · Phone: 813-975-8690
Official record on ClinicalTrials.gov — NCT06837181
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.